Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

31.62
-0.4700-1.46%
Post-market: 31.620.00000.00%19:51 EDT
Volume:1.71M
Turnover:54.73M
Market Cap:3.97B
PE:-22.10
High:33.00
Open:32.09
Low:31.37
Close:32.09
52wk High:41.14
52wk Low:10.83
Shares:125.46M
Float Shares:109.51M
Volume Ratio:1.28
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.59
PE(LYR):-20.66

Loading ...

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Toronto Stock Exchange Hits Record High as Oil Prices Rise

TIPRANKS
·
Aug 13

Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue?

Simply Wall St.
·
Aug 10

Amylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings

Simply Wall St.
·
Aug 08

Emera Inc. CEO on board with plans to boost energy infrastructure in Maritimes

Bloomberg
·
Aug 07

Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data

TIPRANKS
·
Aug 07

Amylyx Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q2 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Amylyx Q2 FY26 Net Loss Widens to $43.4 Million; SG&A Expenses Climb to $21.9 Million

Reuters
·
Aug 06

RAmylyx Pharma Q2 EPS $(0.39) Misses $(0.36) Estimate, Cash & Equivalents $279.8M. Cash runway Expected To Fund Operations Till 2028

Benzinga Earnings
·
Aug 06

Amylyx Pharmaceuticals Q2 EPS USD -0.39 Vs. IBES Estimate USD -0.36

Reuters
·
Aug 06

Amylyx Pharmaceuticals, - Cash Runway Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 06

Press Release: Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Amylyx Pharmaceuticals Inc Expected to Post a Loss of 36 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Press Release: Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Aug 03

Amylyx Pharmaceuticals Schedules Quarterly Results Call

Reuters
·
Aug 03

Amylyx price target raised to $26 from $20 at Citi

TIPRANKS
·
Aug 03

TAKAOKA TOKO Sets Out FY2026 Q1 Financial Overview for Its Energy Network Business

TIPRANKS
·
Jul 30

Fuel costs on the rise as latest geopolitical turmoil drives up crude oil prices

Bloomberg
·
Jul 24